Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Profit After Tax (2024 - 2025)

Historic Profit After Tax for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $1.9 million.

  • Neuphoria Therapeutics' Profit After Tax rose 19592.16% to $1.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.7 million, marking a year-over-year change of. This contributed to the annual value of -$400000.0 for FY2025, which is 9741.94% up from last year.
  • Neuphoria Therapeutics' Profit After Tax amounted to $1.9 million in Q4 2025, which was up 19592.16% from -$9.9 million recorded in Q3 2025.
  • Neuphoria Therapeutics' Profit After Tax's 5-year high stood at $11.3 million during Q1 2025, with a 5-year trough of -$9.9 million in Q3 2025.